BSEDipna Pharmachem Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 2 Jul, 2026 · 21:18 IST

FY26 PAT surges 170% to Rs 263 lakh led by steel segment

Pat Growth 25pctNegative Operating CashflowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹6.00
prior close
₹6.06
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.3% vs market
Pharmaceuticals peers, median of 165sector+0.2%-0.2% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+3.1
15m
+3.1
30m
+2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0-0.3+0.3+0.2-0.2
Next day
+0.0-0.1+0.1-0.3+0.3
2d
-4.5-0.8-3.7-0.5-4.0
3d
-6.3-2.8-3.5-1.2-5.1
4d
+5.0-1.0+6.0-0.7+5.7
5d
-3.2+0.4-3.6-0.1-3.1
1w
-7.2-0.5-6.7+0.6-7.8
15d
-16.0-1.9-14.1-1.8-14.2
1m
-17.8+0.4-18.3-0.5-17.3
2m
-3.3+3.5-6.8+0.9-4.3
3m
-28.7+2.0-30.7+0.4-29.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved audited FY26 results on 2 July 2026. Revenue from operations rose about 3% YoY to Rs 12,908 lakh (vs Rs 12,492 lakh). PAT jumped 170% to Rs 263 lakh (vs Rs 97 lakh), with EPS at Rs 1.00 (vs Rs 0.41). Steel segment turned in Rs 867 lakh profit versus Rs 18 lakh last year, while chemicals segment swung to a Rs 512 lakh loss from a Rs 124 lakh profit. Auditor Devadiya and Associates gave an unmodified opinion. Operating cash flow stayed negative at minus Rs 1,832 lakh versus minus Rs 919 lakh. No deviation reported in use of preferential warrant issue proceeds.

Likely market impact

Strong headline PAT growth driven by steel, but chemicals turned loss-making and operating cash flow remains deeply negative — mixed picture for shareholders.